GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entia Biosciences Inc (OTCPK:ERGO) » Definitions » Other Liabilities for Banks

Entia Biosciences (Entia Biosciences) Other Liabilities for Banks


View and export this data going back to 2007. Start your Free Trial

What is Entia Biosciences Other Liabilities for Banks?

Other Liabilities (Bank) only applies to banks.


Entia Biosciences (Entia Biosciences) Business Description

Traded in Other Exchanges
N/A
Address
13565 South West Tualatin-Sherwood Road, Suite 800, Sherwood, OR, USA, 97140
Entia Biosciences Inc operates as a biotechnology company, is engaged in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products, principally in the United States of America. It market nutraceutical products under the name GROH and SANO directly to the consumers online. It currently offers natural organic nutraceutical mushroom dietary supplement products, ImmuSANO, GlucoSANO, and GROH, which has been designed to nutritionally support hair follicles and nail beds. It derives its revenue from the sale of its GROH line and mushroom-based nutraceutical dietary supplement products and functional ingredients.
Executives
Carl J Johnson director, officer: President and CEO
Hausman Marvin S Md director, officer: Chairman, CSTO 825 THIRD AVE, 40TH FL, NEW YORK NY 10022
Anka Capital Ltd 10 percent owner ROOM 2204 22F WEST TOWER SHUN TAK CENTRE, 200 CONNAUGHT ROAD CENTRAL, SHEUNG WAN K3 -
Cheuk Ho Tam 10 percent owner ROOM 2204 22F WEST TOWER SHUN TAK CENTER, 200 CONNAUGHT ROAD CENTRAL, SHEUNG WAN K3 -
Wah On Wong 10 percent owner ROOM 2204 22F WEST TOWER SHUN TAK CENTER, 200 CONNAUGHT ROAD CENTRAL, SHEUNG WAN K3 -